References
- Auterhoff H, Frauendorf H, Liesenklas W, et al. The chief constituents of gamboge resins. 1. Chemistry of gamboge. Arch Pharm. 1962;295:833–846.
- Zhang ZH, Wang XP, Waddad YA, et al. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv. 2013;20:86–93.
- Wang XP, Lv HX, Waddad AY, et al. Studies on intestinal absorption kinetics of gambogic acid by rat single pass perfusion in situ. China J Chin Materia Med. 2012;37:2079–2083.
- Yu J, Guo QL, You QD, et al. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis. 2007;28:632–638.
- Guo QL, Qi Q, You QD, et al. Toxicological studies of gambogic acid and its potential targets in experimental animals. Basic Clin Pharmacol Toxicol. 2006;99:178–184.
- Pandey MK, Sung B, Ahn KS, et al. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood. 2007;110:3517–3525.
- Kasibhatla S, Jessen KA, Maliartchouk S, et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA. 2005;102:12095–12100.
- Yasuhiro M. Polymeric micellar delivery systems in oncology. Jpn J Clin Oncol. 2008;38:793–802.
- Mahmud A, Xiong XB, Aliabadi HM, et al. Polymeric micelles for drug targeting. J Drug Target. 2007;15:553–584.
- Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 2006;112:630–648.
- Aliabadi HM, Lavasanifar A. Polymeric micelles for drug delivery. Expert Opin Drug Deliv. 2006;3:139–162.
- Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73:137–172.
- Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2009;71:409–419.
- Qu G, Zhu X, Zhang C, et al. Modified chitosan derivative micelle system for natural anti-tumor product gambogic acid delivery. Drug Deliv. 2009;16:363–370.
- Kim IY, Seo SJ, Moon HS, et al. Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv. 2008;26:1–21.
- Varshosaz J. The promise of chitosan microspheres in drug delivery systems. Expert Opin Drug Deliv. 2007;4:263–273.
- Muzzarelli RAA, Muzzarelli C. Chitosan chemistry: relevance to the biomedical sciences. Adv Polym Sci. 2005;186:151–209.
- Dai JG. [Inventor and Assignee]. The preparation of a kind of gambogic acid injection. CHN Patent CN 03131511.9. 2003.
- Yu F, He CH, Ayman YW, et al. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion. Drug Dev Ind Pharm. 2014;40:774–782.
- Zhang ZH, Sarra A, Pan RR, et al. N-octyl-N-arginine chitosan micelles as an oral delivery system of insulin. J Biomed Nanotechnol. 2012;9:1–9.
- Rivolta I, Panariti A, Lettiero B, et al. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. J Physiol Pharmacol. 2011;62:45–53.
- Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm. 2007;345:9–25.
- Patel HM. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst. 1992;9:39–90.
- Hao K, Liu XQ, Wang GJ. Pharmacokinetics of gambogic acid in rats. J China Pharm Univ. 2005;36:338–345.